On (b)(6) 2021, it was reported that this patient on peritoneal dialysis (pd) was hospitalized with peritonitis and may need the pd catheter removed.There were no reported allegations that the event was associated with any issues with fresenius device or product.During additional follow-up, the patient's pd nurse reported that the patient having symptoms of abdominal pain.As a result, on (b)(6) 2021, the patient was seen in the outpatient pd clinic.The patient had a pd culture obtained which yielded growth of staphylococcus epidermis.The patient was treated with vancomycin and fortaz intra-peritoneal (ip) per clinic protocol on an outpatient basis.Additionally, the nurse stated the patient had the pd catheter (not a fresenius product) removed in the hospital (not admitted, performed as an outpatient procedure).The patient is recovering and has transitioned to hemodialysis.The patient's nurse confirmed the patient did not have any fluid leaks or any issues with fresenius device or product in relation to the peritonitis event.The nurse attributed the event to patient breach in aseptic technique.(b)(4), ce00108490.This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|